Thomson Reuters has announced the completion of the $1.25 billion sale of the Thomson Reuters Healthcare business to an affiliate of Veritas Capital. The company's many well-known brands, established in more than 30 years of leadership in the healthcare industry, include Advantage Suite, Action OI, MarketScan, 100 Top Hospitals, CareDiscovery and Micromedex.
The new independent company will be known as Truven Health Analytics, a name based on the words 'truth' and 'proven' that speaks to the strength of its offerings, expertise, and people.
Truven Health Analytics will provide data, analytics and performance benchmarking solutions and services to hospitals, health systems, employers, health plans, government agencies and pharmaceutical companies. With leading assets and solutions coupled with expert services and analysis, the company provides its customers with solutions to identify savings, improve outcomes, detect fraud, and more efficiently manage their healthcare operations.
Truven Health Analytics is uniquely positioned to address the industry's convergent healthcare trends, including the increased use of benchmarks to assess quality care, implementation of health information exchanges and other electronic data initiatives spurred by healthcare reform, more rigorous investigations of healthcare waste and abuse, and the development of population health programs among hospitals, health plans, and large employers.
